SCHEMBL257516

SCHEMBL257516

Cc1nn2c(-c3ccccc3)cc(N3CCC[C@H]3CO)nc2c1-c1ccc2c(c1)OCO2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ MAPT P10636 4/20 0.41
▸ ITGB2 P05107 1/20 0.40
▸ ICAM1 P05362 1/20 0.40
▸ ITGAL P20701 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ BCL6 P41182 1/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ MAT2A P31153 1/20 0.39
▸ SCD5 Q86SK9 1/20 0.38
▸ SYK P43405 2/20 0.38
▸ NOS2 P35228 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020929 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL15020822 0.93 FPR2 (0.41) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL15020578 0.91 LMNA (0.40) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL15020607 0.91 ITGB2 (0.39) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL257696 0.90 ITGB2 (0.40) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL15020592 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTITGB2ICAM1
SCHEMBL15042196 0.89 MAPT (0.53) ALDH1A1KDM4EMAPTTP53BCL6
SCHEMBL15042156 0.87 MAPT (0.49) ALDH1A1KDM4EMAPTTP53BCL6
SCHEMBL15020749 0.87 MAPT (0.49) ALDH1A1KDM4EMAPTTP53BCL6
SCHEMBL15042187 0.85 MAPT (0.47) ALDH1A1KDM4EMAPTTP53BCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
EP-2617723-A2 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR Amorepacific Corporation (KR) 2013-07-24 — — EP disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
WO-2012030170-A2 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR (주)아모레퍼시픽 (KR) 2012-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR CNR1, CNR2, GPR18 ALDH1A1 2139/4885KDM4E 2294/4885MAPT 2617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback